Bulletin
Investor Alert

New York Markets Close in:

Illumina Inc.

NAS: ILMN

GO
/marketstate/country/us

Market open

 --Real time quotes

Dec 2, 2021, 12:25 p.m.

/zigman2/quotes/203509482/composite

$

358.82

Change

+1.16 +0.32%

Volume

Volume 474,847

Real time quotes

/zigman2/quotes/203509482/composite

Previous close

$ 357.66

$ 358.82

Change

+1.16 +0.32%

Day low

Day high

$351.34

$360.78

Open

52 week low

52 week high

$335.68

$555.77

Open

Charles E. Dadswell

Charles E. Dadswell holds the position of Secretary, Senior VP & Compliance Officer at Illumina, Inc.

In his past career he was General Counsel of BioDelivery Sciences International, Inc., Vice President-US Intellectual Property at GlaxoSmithKline, Inc., Principal at Glaxo Wellcome, Inc. and VP & General Counsel-North & Latin America at bioMerieux, Inc.

He received an undergraduate degree from Ferris State University (Michigan), a graduate degree from The Thomas M. Cooley Law School and a graduate degree from George Washington University Law School.

Transactions

Date Shares Transaction Value
11/22/2021 314   Disposition at $377.86 per share. 118,649
11/05/2021 739   Derivative/Non-derivative trans. at $408.14 per share. 301,616
10/22/2021 314   Disposition at $411 per share. 129,054
09/22/2021 314   Disposition at $436.69 per share. 137,121
08/23/2021 314   Disposition at $489.1 per share. 153,578
07/22/2021 314   Disposition at $482.23 per share. 151,421
06/22/2021 314   Disposition at $461.01 per share. 144,758
05/24/2021 314   Disposition at $403.04 per share. 126,555
04/22/2021 314   Disposition at $402.02 per share. 126,235
03/22/2021 314   Disposition at $416.24 per share. 130,700
02/17/2021 1,635   Derivative/Non-derivative trans. at $494.24 per share. 808,083
02/17/2021 3,503   Derivative/Non-derivative trans. at $0 per share. 0
02/17/2021 386   Award at $0 per share. 0
02/09/2021 1,380   Award at $0 per share. 0
12/01/2020 1,694   Disposition at $323.86 per share. 548,619
11/05/2020 882   Derivative/Non-derivative trans. at $311.72 per share. 274,938
11/02/2020 121   Disposition at $298 per share. 36,058
10/01/2020 121   Disposition at $312.82 per share. 37,852
09/01/2020 1,687   Disposition at $355.35 per share. 599,476
08/03/2020 121   Disposition at $385.19 per share. 46,608
07/01/2020 121   Disposition at $369.26 per share. 44,681
06/01/2020 1,686   Disposition at $362.6 per share. 611,344
05/01/2020 121   Disposition at $317.16 per share. 38,377
04/01/2020 121   Disposition at $265.92 per share. 32,177
03/02/2020 1,686   Disposition at $268.02 per share. 451,882
02/11/2020 5,174   Derivative/Non-derivative trans. at $296 per share. 1,531,504
02/11/2020 7,624   Derivative/Non-derivative trans. at $0 per share. 0
02/11/2020 3,812   Award at $0 per share. 0
02/05/2020 1,873   Award at $0 per share. 0
12/02/2019 655   Disposition at $320.33 per share. 209,817
11/05/2019 820   Derivative/Non-derivative trans. at $300.87 per share. 246,714
11/01/2019 193   Disposition at $297.28 per share. 57,376
10/01/2019 124   Disposition at $304.22 per share. 37,724
09/03/2019 1,220   Disposition at $279.88 per share. 341,454
08/01/2019 124   Disposition at $300 per share. 37,200
07/01/2019 124   Disposition at $371.29 per share. 46,040
06/03/2019 180   Disposition at $311.82 per share. 56,128
06/03/2019 220   Disposition at $311.09 per share. 68,440
06/03/2019 400   Disposition at $310.06 per share. 124,024
06/03/2019 120   Disposition at $308.7 per share. 37,044
06/03/2019 220   Disposition at $307.63 per share. 67,679
06/03/2019 80   Disposition at $306.58 per share. 24,527
05/01/2019 124   Disposition at $311.77 per share. 38,660
04/01/2019 124   Disposition at $314.45 per share. 38,992
03/01/2019 1,220   Disposition at $313.93 per share. 382,995
02/12/2019 1,974   Derivative/Non-derivative trans. at $292.2 per share. 576,803
02/12/2019 867   Award at $0 per share. 0
02/12/2019 4,127   Derivative/Non-derivative trans. at $0 per share. 0
02/01/2019 124   Disposition at $280.11 per share. 34,734
01/02/2019 124   Disposition at $294.71 per share. 36,545
12/11/2018 1,521   Award at $0 per share. 0
12/03/2018 566   Disposition at $343.57 per share. 194,461
11/05/2018 796   Derivative/Non-derivative trans. at $324.14 per share. 258,016
04/03/2018 116   Disposition at $230.91 per share. 26,786
03/05/2018 145   Disposition at $227.17 per share. 32,940
02/15/2018 1,319   Derivative/Non-derivative trans. at $229.13 per share. 302,223
02/15/2018 3,792   Derivative/Non-derivative trans. at $0 per share. 0
02/05/2018 1,610   Disposition at $221.45 per share. 356,535
01/29/2018 220   Derivative/Non-derivative trans. at $241.78 per share. 53,192
01/03/2018 145   Disposition at $224.5 per share. 32,553
12/11/2017 1,168   Award at $0 per share. 0
12/04/2017 145   Disposition at $225.33 per share. 32,673
11/06/2017 684   Derivative/Non-derivative trans. at $209.19 per share. 143,086
11/03/2017 1,609   Disposition at $207.88 per share. 334,479
10/03/2017 145   Disposition at $202.23 per share. 29,324
09/05/2017 145   Disposition at $205.71 per share. 29,828
08/03/2017 1,609   Disposition at $197 per share. 316,973
07/03/2017 145   Disposition at $174.24 per share. 25,265
06/05/2017 145   Disposition at $184.75 per share. 26,789
05/03/2017 1,609   Disposition at $187.07 per share. 300,996
04/24/2017 979   Derivative/Non-derivative trans. at $180.2 per share. 176,416
02/15/2017 4,691   Derivative/Non-derivative trans. at $163.29 per share. 765,994
02/15/2017 3,516   Award at $0 per share. 0
02/15/2017 7,032   Derivative/Non-derivative trans. at $0 per share. 0
02/06/2017 572   Disposition at $161.26 per share. 92,241
01/30/2017 256   Derivative/Non-derivative trans. at $159.28 per share. 40,776
01/10/2017 116   Disposition at $161.6 per share. 18,746
12/02/2016 2,542   Award at $0 per share. 0

Officers and Executives

Mr. Francis A. deSouza
President, Chief Executive Officer & Director
Mr. Robert P. Ragusa
Chief Operations Officer
Mr. Sam A. Samad
Chief Financial Officer & Senior Vice President
Dr. Alex Aravanis
CTO, Head-Research & Product Development
Mr. Steve Phillpott
Chief Information Officer & Senior Vice President
Dr. Phillip G. Febbo
Chief Medical Officer
Dr. Joydeep Goswami
SVP-Corporate Development & Strategic Planning
Mr. Min-Jui Shen
Director-Scientific Operations & Research
Ms. Susan H. Tousi
Chief Commercial Officer
Mr. Charles E. Dadswell
Secretary, Senior VP & Compliance Officer
Ms. Paula Lynn Dowdy
SVP & GM-Commercial Operations, Europe
Ms. Kathy Reeves
Chief Marketing Officer
Mr. Jose A. Torres
Chief Accounting Officer & Vice President
Ms. Juliet C. Cunningham
Vice President-Investor Relations
Ms. Aimee Hoyt
Chief People Officer & Senior Vice President
Dr. John Wendell Thompson
Chairman
Dr. Scott Gottlieb
Independent Director
Dr. Robert S. Epstein
Independent Director
Dr. Frances Hamilton Arnold
Independent Director
Mr. Philip W. Schiller
Independent Director
Ms. Caroline D. Dorsa
Independent Director
Dr. Gary S. Guthart
Independent Director
Ms. Susan E. Siegel
Independent Director
Trending Tickers
  • /zigman2/quotes/200467500/composite NVDA+6.20%
  • /zigman2/quotes/201948298/composite BABA-5.69%
  • /zigman2/quotes/202092269/composite ENSC+36.10%
  • /zigman2/quotes/200164174/composite SNOA+74.50%
  • /zigman2/quotes/207683784/composite TIGR-10.38%
X
Powered by StockTwits
Link to MarketWatch's Slice.